Cargando…
Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
Building upon the resounding therapeutic success of monoclonal antibodies, and supported by accelerating progress in engineering methods, the field of multispecific therapeutic antibodies is growing rapidly. Over 140 different molecules are currently in clinical testing, with excellent results in re...
Autores principales: | Elshiaty, Mariam, Schindler, Hannah, Christopoulos, Petros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198225/ https://www.ncbi.nlm.nih.gov/pubmed/34073188 http://dx.doi.org/10.3390/ijms22115632 |
Ejemplares similares
-
Breaking Bottlenecks for the TCR Therapy of Cancer
por: Gaissmaier, Lena, et al.
Publicado: (2020) -
Toward Drug-Like Multispecific Antibodies by Design
por: Sawant, Manali S., et al.
Publicado: (2020) -
Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987) -
Multispecific Antibodies: DNA‐Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing (Adv. Sci. 2/2020)
por: Pan, Liqiang, et al.
Publicado: (2020) -
The use of CrossMAb technology for the generation of bi- and multispecific antibodies
por: Klein, Christian, et al.
Publicado: (2016)